# Nuclide record jnj-87189401 (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/jnj-87189401/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "jnj-87189401" ;
  schema:name "JNJ-87189401"@en ;
  schema:description "JNJ-87189401 is an experimental costimulatory agent from Janssen Research & Development in phase 3 trials for prostate cancer, aimed at PSMA."@en ;
  schema:url <https://nuclide.cc/drugs/jnj-87189401/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=JNJ-87189401> ;
  nuclide:status "phase-3" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:modality "costimulatory bispecific antibody (PSMA x CD28, per the sponsor's pipeline page)" ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:targets <https://nuclide.cc/targets/psma/> ;
  nuclide:companies <https://nuclide.cc/companies/johnson-johnson/> ;
  nuclide:trials <https://nuclide.cc/trials/mcrpc/> .